Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Profound Medical (PROF) Retained Earnings (2023 - 2025)

Profound Medical has reported Retained Earnings over the past 3 years, most recently at -$287.7 million for Q4 2025.

  • Quarterly results put Retained Earnings at -$287.7 million for Q4 2025, down 17.36% from a year ago — trailing twelve months through Dec 2025 was -$287.7 million (down 17.36% YoY), and the annual figure for FY2025 was -$287.7 million, down 17.36%.
  • Retained Earnings for Q4 2025 was -$287.7 million at Profound Medical, down from -$279.6 million in the prior quarter.
  • Over the last five years, Retained Earnings for PROF hit a ceiling of $5.6 million in Q4 2023 and a floor of -$287.7 million in Q4 2025.
  • Median Retained Earnings over the past 3 years was -$250.5 million (2024), compared with a mean of -$176.2 million.
  • Biggest five-year swings in Retained Earnings: crashed 4505.57% in 2024 and later decreased 17.36% in 2025.
  • Profound Medical's Retained Earnings stood at $5.6 million in 2023, then crashed by 4505.57% to -$245.2 million in 2024, then decreased by 17.36% to -$287.7 million in 2025.
  • The last three reported values for Retained Earnings were -$287.7 million (Q4 2025), -$279.6 million (Q3 2025), and $5.6 million (Q2 2025) per Business Quant data.